We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

An Imaging Trial of the Distribution of Topical Gel Formulations in the Human Vagina

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00214747
Recruitment Status : Unknown
Verified September 2005 by Biosyn.
Recruitment status was:  Active, not recruiting
First Posted : September 22, 2005
Last Update Posted : October 25, 2005
Information provided by:

Study Description
Brief Summary:
This study is designed to assess the distribution and spread of four different vehicle formulations in the vagina. In-vivo data will be obtained regarding each vehicle formulation at various time points after insertion of the gel into the vagina.

Condition or disease Intervention/treatment Phase
HIV Infections Drug: Vehicle gel formulations Phase 1

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 6 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double
Primary Purpose: Diagnostic
Official Title: An Imaging Trial of the Distribution of Topical Gel Formulations in the Human Vagina: Candidate Formulations
Study Start Date : March 2005
Estimated Study Completion Date : November 2005

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS
U.S. FDA Resources

Arms and Interventions

Outcome Measures

Primary Outcome Measures :
  1. MRI evaluation of gel formulation distribution in vagina
  2. Total linear distance in mm covered by gel
  3. Surface area actually covered by gel (mm)

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • 18 to 45 year old women
  • non-pregnant
  • healthy

Exclusion Criteria:

  • abnormal finding on pelvic exam
  • pregnant or breastfeeding
  • allergy to intravaginal products
  • history of claustrophobia
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00214747

United States, Pennsylvania
Rreproductive Research Unit, U of Penn Medical Center
Philadelphia, Pennsylvania, United States, 19104
Sponsors and Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
Principal Investigator: Kurt Barnhart, MD University of Pennsylvania
More Information

ClinicalTrials.gov Identifier: NCT00214747     History of Changes
Other Study ID Numbers: RRU-003
First Posted: September 22, 2005    Key Record Dates
Last Update Posted: October 25, 2005
Last Verified: September 2005

Keywords provided by Biosyn:
HIV Seronegativity

Additional relevant MeSH terms:
HIV Infections
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases